![James E. Pelot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James E. Pelot
Financieel Directeur/CFO bij ArcticDX, Inc.
Profiel
James E.
Pelot is currently the Chief Operating & Financial Officer at ArcticDX, Inc. He previously worked as a Non-Executive Director at Optiva, Inc., a Principal at Nortel Networks Corp., and as the Chief Operating & Financial Officer at Tm Bioscience Corp.
He also served as the Chief Financial Officer at Luminex Molecular Diagnostics, Inc. Mr. Pelot obtained his undergraduate degree from the University of Ottawa.
Actieve functies van James E. Pelot
Bedrijven | Functie | Begin |
---|---|---|
ArcticDX, Inc.
![]() ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Financieel Directeur/CFO | - |
Eerdere bekende functies van James E. Pelot
Bedrijven | Functie | Einde |
---|---|---|
Tm Bioscience Corp.
![]() Tm Bioscience Corp. BiotechnologyHealth Technology Tm Bioscience Corp. developed DNA-based diagnostics tests. It developed a suite of genetic tests that include tests for genetic disorders, drug metabolism and infectious diseases. Tm Bioscience was founded on December 19, 1980 and was headquartered in Toronto, Canada. | Financieel Directeur/CFO | 01-03-2007 |
NORTEL NETWORKS CORPORATION (USA) | Corporate Officer/Principal | - |
Luminex Molecular Diagnostics, Inc.
![]() Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. | Financieel Directeur/CFO | - |
OPTIVA INC. | Directeur/Bestuurslid | - |
Opleiding van James E. Pelot
University of Ottawa | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OPTIVA INC. | Technology Services |
Bedrijven in privébezit | 4 |
---|---|
Nortel Networks Corp.
![]() Nortel Networks Corp. Financial ConglomeratesFinance Nortel Networks Corp. supplies end-to-end networking products and solutions serving both service providers and enterprise customers. It designs, develops, engineers, markets, sells, supplies, licenses, installs, services, and supports networking solutions worldwide. The company was founded in 1895 and is headquartered in Mississauga, Canada. | Finance |
Tm Bioscience Corp.
![]() Tm Bioscience Corp. BiotechnologyHealth Technology Tm Bioscience Corp. developed DNA-based diagnostics tests. It developed a suite of genetic tests that include tests for genetic disorders, drug metabolism and infectious diseases. Tm Bioscience was founded on December 19, 1980 and was headquartered in Toronto, Canada. | Health Technology |
Luminex Molecular Diagnostics, Inc.
![]() Luminex Molecular Diagnostics, Inc. Medical/Nursing ServicesHealth Services Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm’s products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada. | Health Services |
ArcticDX, Inc.
![]() ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |